Han D, Wu Z, Zhang C, Wei Z, Chao F, Xie X
Cell Death Discov. 2025; 11(1):10.
PMID: 39820478
PMC: 11739388.
DOI: 10.1038/s41420-025-02288-0.
Zhang S, Ren L, Li W, Zhang Y, Yang Y, Yang H
Cell Oncol (Dordr). 2024; 47(5):1593-1605.
PMID: 39141317
DOI: 10.1007/s13402-024-00979-x.
Lail S, Balce D, Canton J, Yates R
Methods Mol Biol. 2023; 2692:139-152.
PMID: 37365466
DOI: 10.1007/978-1-0716-3338-0_10.
Huang Y, Yang F, Zhang W, Zhou Y, Duan D, Liu S
Front Genet. 2023; 14:1135365.
PMID: 37065491
PMC: 10098196.
DOI: 10.3389/fgene.2023.1135365.
Abed H, Abuwatfa W, Husseini G
Nanomaterials (Basel). 2022; 12(18).
PMID: 36144971
PMC: 9503659.
DOI: 10.3390/nano12183183.
Fluorescent Probes Design Strategies for Imaging Mitochondria and Lysosomes.
Chen H, Yu Z, Ren S, Qiu Y
Front Pharmacol. 2022; 13:915609.
PMID: 35928260
PMC: 9343947.
DOI: 10.3389/fphar.2022.915609.
GILT Expression in Human Melanoma Cells Enhances Generation of Antigenic Peptides for HLA Class II-Mediated Immune Recognition.
Hathaway-Schrader J, Norton D, Hastings K, Doonan B, Fritz S, Bethard J
Int J Mol Sci. 2022; 23(3).
PMID: 35162988
PMC: 8835040.
DOI: 10.3390/ijms23031066.
Trichinella spiralis: Knockdown of gamma interferon inducible lysosomal thiol reductase (GILT) results in the reduction of worm burden.
Fei H, Naqvi M, Naqvi S, Xu L, Song X, Li X
PLoS Negl Trop Dis. 2021; 15(11):e0009958.
PMID: 34847145
PMC: 8631631.
DOI: 10.1371/journal.pntd.0009958.
Redox-Responsive Mesoporous Silica Nanoparticles for Cancer Treatment: Recent Updates.
Gisbert-Garzaran M, Vallet-Regi M
Nanomaterials (Basel). 2021; 11(9).
PMID: 34578538
PMC: 8468083.
DOI: 10.3390/nano11092222.
IFI30 expression predicts patient prognosis in breast cancer and dictates breast cancer cells proliferation via regulating autophagy.
Fan Y, Wang X, Li Y
Int J Med Sci. 2021; 18(14):3342-3352.
PMID: 34400904
PMC: 8364447.
DOI: 10.7150/ijms.62870.
A connexin/ifi30 pathway bridges HSCs with their niche to dampen oxidative stress.
Cacialli P, Mahony C, Petzold T, Bordignon P, Rougemont A, Bertrand J
Nat Commun. 2021; 12(1):4484.
PMID: 34301940
PMC: 8302694.
DOI: 10.1038/s41467-021-24831-0.
Unveiling the keratinolytic transcriptome of the black carpet beetle (Attagenus unicolor) for sustainable poultry feather recycling.
Keefe M, Lei X
Appl Microbiol Biotechnol. 2021; 105(13):5577-5587.
PMID: 34226961
DOI: 10.1007/s00253-021-11427-3.
Fluorescent Probes for Live Cell Thiol Detection.
Wang S, Huang Y, Guan X
Molecules. 2021; 26(12).
PMID: 34208153
PMC: 8230801.
DOI: 10.3390/molecules26123575.
Disulfide-containing Macromolecules for Therapeutic Delivery.
Jiang Z, Thayumanavan S
Isr J Chem. 2021; 60(1-2):132-139.
PMID: 34168383
PMC: 8221575.
DOI: 10.1002/ijch.201900160.
Expression of gilt acts as a positive regulator of mouse hematopoietic progenitor cells.
Broxmeyer H, Cooper S, Blum J
Blood Cells Mol Dis. 2021; 90:102574.
PMID: 34015674
PMC: 8338767.
DOI: 10.1016/j.bcmd.2021.102574.
A non-immunological role for γ-interferon-inducible lysosomal thiol reductase (GILT) in osteoclastic bone resorption.
Ewanchuk B, Arnold C, Balce D, Premnath P, Orsetti T, Warren A
Sci Adv. 2021; 7(17).
PMID: 33893096
PMC: 8064644.
DOI: 10.1126/sciadv.abd3684.
Interferon-gamma-activated macrophages infected with Burkholderia cenocepacia process and present bacterial antigens to T-cells by class I and II major histocompatibility complex molecules.
Rosales-Reyes R, Garza-Villafuerte P, Vences-Vences D, Aubert D, Aca-Teutle R, Ortiz-Navarrete V
Emerg Microbes Infect. 2020; 9(1):2000-2012.
PMID: 32873215
PMC: 7534305.
DOI: 10.1080/22221751.2020.1818632.
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-Antigen.
Rausch M, Meador L, Metzger T, Li H, Qiu S, Anderson M
J Immunol. 2020; 204(11):2877-2886.
PMID: 32269095
PMC: 7336541.
DOI: 10.4049/jimmunol.1900523.
Antibody-Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome-Disruptive Peptide.
Knewtson K, Perera C, Hymel D, Gao Z, Lee M, Peterson B
ACS Omega. 2019; 4(7):12955-12968.
PMID: 31460422
PMC: 6690568.
DOI: 10.1021/acsomega.9b01585.
A Phase I/II Trial of MEC (Mitoxantrone, Etoposide, Cytarabine) in Combination with Ixazomib for Relapsed Refractory Acute Myeloid Leukemia.
Advani A, Cooper B, Visconte V, Elson P, Chan R, Carew J
Clin Cancer Res. 2019; 25(14):4231-4237.
PMID: 30992301
PMC: 6635077.
DOI: 10.1158/1078-0432.CCR-18-3886.